Avicularin: The major secondary metabolite isolated from Saurauia vulcani as a potential anti-colorectal cancer agent

Gunawan Pasaribu, Sumi Hudiyono, Antonius Herry Cahyana, Gustan Pari, Andi Rifki Rosandi, Sofa Fajriah

Research output: Contribution to journalArticlepeer-review

Abstract

Saurauia vulcani flora develops certainly in North Sumatra Province, Indonesia. It is normally consumed as an antidiabetic remedy and a treatment related to digestion diseases. This research aims to isolate the major compound from S. vulcani plants and assess the bioactivity of the S. vulcani plant for its anti-colorectal cancer potential. Subsequently, the ethyl acetate fraction was analyzed with a solvent system used as the eluent ethyl acetate: methanol: Aquadest = 4.6:0.2:0.2. Utilizing spectroscopy, we determined the chemical structure of the remote substance. Utilizing the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide technique in vitro, the anti-colorectal cancer activity was demonstrated against WiDr cancer cells. This study revealed that the major compound was identified as avicularin. The avicularin compound is a flavonoid group known to have anticancer activity. The cytotoxicity of avicularin compound was assessed against the WiDr cell line, with a 50% inhibition concentration value of 521.14 μg/ml. The bioactivity of the ethyl acetate fraction is stronger than that of the isolated part (avicularin compound).

Original languageEnglish
Pages (from-to)101-110
Number of pages10
JournalJournal of Applied Pharmaceutical Science
Volume13
Issue number11
DOIs
Publication statusPublished - Nov 2023

Keywords

  • avicularin
  • colorectal cancer
  • extract
  • plant leaves
  • Saurauia vulcani

Fingerprint

Dive into the research topics of 'Avicularin: The major secondary metabolite isolated from Saurauia vulcani as a potential anti-colorectal cancer agent'. Together they form a unique fingerprint.

Cite this